RSV is a common and highly contagious respiratory virus that is a leading cause of lung disease. RSV is seasonal, and like other respiratory viruses, its peak incidence is during the winter months each year. It spreads from person to person via droplets, or from infected surfaces or objects. RSV is a virus, so antibiotics are not effective.

Arexvy is a new vaccination designed to protect against lower respiratory tract disease caused by respiratory syncytial virus (RSV). It is an important advance, because no specific treatment for RSV is available, and infection is often severe.

Older adults, and those with underlying medical conditions such as diabetes, heart disease and lung diseases such as asthma and COPD are at the greatest risk of the infection. RSV can exacerbate these underlying conditions and lead to pneumonia.

In the UK, RSV causes more hospitalisations and deaths than flu in those over the age of 60. It is estimated that RSV causes14,000 hospitalisations and an estimated 8,000 deaths in adults 60 years of age and older each year.

Arexvy is a recombinant adjuvanted vaccine for the prevention of RSV is adults 60 years of age and above. It is the only licensed vaccination in the UK that has been authorised for use by the Medicines and Healthcare products Regulatory Agency, meaning at risk adults are now able to be vaccinated against the disease.

Arexvy is as in inactive vaccination and only requires single dose for protection. It can be administered at the same time as other vaccinations including flu, pneumococcal, and COVID.

We are among the first practices in the UK to offer it to adults needing protection.

As a private healthcare clinic, our goal is to provide the best protection against pneumonia for our patients. One of the key tools in this fight is the pneumococcal vaccine. One of the latest advancements in this area is the Apexxnar vaccine. This 20-valent vaccine provides protection against 20 different serotypes of the pneumococcal bacteria, offering a more comprehensive defence against pneumonia. 

We understand that choosing the right vaccine can be complex and that different patients may require different solutions. That’s why we recommend speaking with one of our healthcare providers to determine which vaccine, including Apexxnar, is best for you. They will consider risk factors such as your age, underlying health conditions, and previous vaccinations, to ensure you receive the most effective protection against pneumonia. 

At Fleet St. Clinic, we believe in the power of prevention, and that the right vaccine can make all the difference. So, if you’re looking for the best defence against pneumonia, consider talking to us about the Apexxnar vaccine today. 

Information about Pneumonia: 

Pneumonia is a lung infection that can cause a range of symptoms, including: 

1. Cough: A persistent cough that produces mucus or phlegm is a common symptom of pneumonia. The cough may be dry or productive, and the mucus or phlegm may be green, yellow, or rust-coloured. 
2. Fever: Pneumonia often causes a high fever, which may be accompanied by chills and sweats. 
3. Shortness of breath: Pneumonia can cause difficulty breathing, especially during physical activity. The shortness of breath may be accompanied by chest pain or tightness. 
4. Fatigue: Pneumonia can cause extreme tiredness and weakness, making it difficult to carry out normal daily activities. 
5. Muscle aches: Pneumonia can cause muscle aches and joint pain, which may be mistaken for the flu. 
6. Chest pain: Pneumonia can cause chest pain, especially when breathing deeply or coughing. 
7. Nausea and vomiting: Some people with pneumonia may experience nausea and vomiting, especially if the infection is caused by a type of bacteria known as Legionella. 
8. Confusion or disorientation: Pneumonia can cause confusion or disorientation, especially in older adults and people with underlying health conditions. 

It’s important to seek medical attention if you experience any of these symptoms, as pneumonia can be a serious and potentially life-threatening condition.
More information on pneumonia. 

Who is considered “high-risk”? 

Individuals considered to be at high risk for hospitalisation due to pneumonia include the elderly, young children, people with weakened immune systems (including people who have had their spleen removed), and individuals with underlying health conditions such as chronic heart or lung diseases, diabetes, and liver or kidney problems. 

At the Fleet St. Clinic, we also regard anyone who has had a previous significant episode of pneumonia as likely to benefit from being vaccinated. 

When is the best time for a pneumonia vaccine? 

The best time to vaccinate against pneumonia depends on various factors such as the type of vaccine, the individual’s age, and underlying health conditions. 

The pneumonia vaccine is not the same as the flu vaccine, as it doesn’t need to be given at a certain time of year. 

For the pneumococcal vaccine, it is generally recommended to receive the vaccine once in a lifetime for most adults. Some individuals may need a booster shot, and this is determined by a healthcare provider such as a doctor or nurse. 

How to book an appointment? 

Booking an appointment is easy. If you are on the go, you can book online through our online booking system, pre-payment is required. 

If you would like to discuss anything further or would like to book with our reception team, you can call them on +44 207 353 5678 or email us at info@fleetstreetclinic.com 

Related services available at Fleet Street Clinic: 

Pneumonia Vaccination

Adult Wellness Vaccinations

Child Wellness Vaccinations

GP Services 

What is HPV?

Human Papillomavirus, or HPV, is the name of a group of viruses with around 200 different types, that is most commonly passed on via genital contact.

Although HPV is highly common, 90% of HPV infections go away by themselves and do not cause any harm. Most people with HPV never develop symptoms or health problems.

However, it is possible for HPV infections to persist and cause cellular change in your body. This can lead to:

• Cancer of the cervix, vulva, and vagina in women
• Precancerous lesions in men and women
• Genital warts in men and women
• Head and neck cancers in men and women

HPV vaccines have a well-established role in preventing cervical cancers as well as these other aforementioned conditions.

Who Should Be Vaccinated against HPV?

In theory, HPV vaccines are best given to young people before they become sexually active, and therefore before they can be exposed to HPV.

Individuals who are already sexually active might also benefit as they may not have yet acquired all of the HPV strains covered by the vaccine. Patients aged under 16 can only be vaccinated with their parents present.

Why Boys should receive the HPV Vaccine

• About 15% of UK girls who are eligible for vaccination are currently not receiving both doses. This figure is much higher in some areas
• Most older women in the UK have not had the HPV vaccination
• Men may have sex with women from other countries which have no vaccination programme
• Men who have sex with men are not protected by the girls’ programme
• The cost of treating HPV-related diseases is high: treating anogenital warts alone in the UK is estimated to cost £58 million a year, while the additional cost of vaccinating boys has been estimated to cost about £20 million a year

Source: HPV Action 

To book an HPV vaccination for yourself or your child, you can book an appointment online. Or find out more information about HPV here.

ESSENTIAL CHICKENPOX VACCINE FACTS: 

• The chickenpox vaccine is not given by the NHS, but is part of the childhood vaccination schedule in other countries
• Chickenpox is a highly contagious infection caused by the varicella zoster virus
• In the UK, it mostly affects children
• It can be itchy and uncomfortable, can leave scars, and can sometimes cause severe disease – adults may suffer more serious symptoms, including pneumonia
• Chickenpox is spread by inhaling droplets coughed up by people infected with the virus
• People with chickenpox become contagious about 2 days before the appearance of the rash, which can make it difficult to avoid infection
• The chickenpox vaccine (varicella vaccine) can be administered from the age of twelve months onwards
• Two doses of vaccine are needed, with a 4 week gap between doses
• If your child is receiving the MMR vaccination or a Yellow Fever vaccine, the varicella vaccination must either be given on the same day, or 4 weeks later

HOW TO BOOK A VACCINATION APPOINTMENT

Fleet Street Clinic is dedicated to maintaining a good supply of the chickenpox vaccine.

Our private chickenpox vaccine service is undertaken by doctors and nurses with long experience of vaccinating children. Our family friendly clinic is sympathetic to parents’ needs and concerns, and we welcome any vaccine-related queries. We operate a Saturday vaccination clinic once a month, the next will be held on Saturday April 8th.

To book your chickenpox vaccination for yourself or your child, you can book online now.

MUMPS OUTBREAKS IN UK UNIVERSITIES:

CASES OF MUMPS REPORTED AT A NUMBER OF UK UNIVERSITIES

Public Health England has confirmed they are urging students to get MMR vaccinations.

A number of cases of mumps have been reported in Nottingham and Exeter. The recent rise in teenagers and young adults who have not had two doses of the MMR vaccine are believed to have caused an increase in UK cases. Unprotected students are particularly vulnerable due to close living conditions. Students are being urged to ensure they have received the full two-dose MMR vaccine course to protect themselves against mumps.

A total of 241 suspected cases were reported, with 52 confirmed, across Nottingham Trent University and the University of Nottingham and 7 confirmed cases at Exeter University.

MUMPS VIRUS

Mumps is a contagious viral infection which causes swelling of the parotid glands.

Initial symptoms can be similar to a cold and include:

• Headache
• High Temperature
• Joint Pain
• Feeling Sick
• Tiredness
• Loss of Appetite
• Swelling of the face/neck

Mumps can result in some serious complications. It can cause temporary hearing loss in 1 in 20 people. Mumps can cause a rare but potential risk of encephalitis, which affects 1 in 1,000 sufferers and requires hospitalisation.

It is spread in the same way as colds and flu – through infected droplets of saliva that can be inhaled or picked up from surfaces and transferred into the mouth or nose.

A person is most contagious a few days before the symptoms develop and for a few days afterwards.

Some people suffer complications that can include inflammation of the pancreas, viral meningitis (inflammation of the brain), inflamed and swollen testicles in men and ovaries in women.

MEDICAL ADVICE FOR MUMPS

If you think you may be suffering from mumps, or are concerned about the risk of infection, please see your doctor straight away.

Those who have not had the MMR vaccine – or have only received one dose – regardless of age, should ensure they receive two doses of the MMR (measles, mumps and rubella) vaccine.

In order to keep virus’ such as mumps from spreading, a certain proportion of the population must be immunised, this is called the ‘herd immunity’.

Herd immunity is particularly important as not everyone can get vaccinated, but those who can are able to help people those who can’t. Some people are unable to get vaccinated because they’re too ill, too young or have an impaired immune system. When we vaccinate, we protect not only ourselves but also the most vulnerable members of our communities.

VACCINATION AGAINST MUMPS

The disease can be easily prevented with two doses of the MMR vaccine, that has safely and efficiently been in use since the late 1980s’.

Make sure you are up-to-date with your measles, mumps and rubella (MMR) vaccine. Although the NHS immunisation schedule offers the vaccine to children from 12 months of age, the MMR can be given from 6 months. If you have not had measles, mumps or rubella or if you have not had two doses of MMR, you may be at risk.  Measles mumps and rubella are easily passed from person to person and can be a serious illness in adults as well as children. It is never too late to have the vaccine.

You can book an MMR vaccine online.

Links:

• Public Health England
  
• BBC News: Why are University students catching mumps?
  
• Devon Live: Fears of mumps outbreak at Exeter University after a surge in cases

At present, there is currently a shortage of Hepatitis B vaccine available in the United Kingdom and across the world.

Despite current global shortages, Fleet Street Clinic maintains good stock levels of the Hepatitis B vaccine.

The Hepatitis B virus is one of the most prevalent blood-borne viruses worldwide and is a major cause of chronic liver disease and liver cancer. In the majority of cases, Hepatitis B is asymptomatic – without symptoms. It is easily preventable through vaccination, and we strongly believe this vaccine should be offered more widely – all young, sexually active adults ought to be protected.

Although the overall risk for travellers is low, Hepatitis B immunisation is recommended for travellers travelling to East Asia and Sub Saharan Africa where between 5 – 10 % of the adult population is estimated to have persistent Hepatitis B infection. High rates of infection are also found in the Amazon, southern parts of eastern and central Europe, the Middle East and Indian subcontinents. The risk understandable increases for long-stay travellers in high-risk areas.

Certain behaviours and activities put individuals at higher risk, such as unprotected sex, adventure sports, body piercing, tattoos and injected drug usage.

Receiving medical or dental care in high-risk countries will also increase your risk and it is advised to avoid unless absolutely necessary. Travellers who have pre-existing conditions which may make it more likely for them to need medical attention should definitely consider the Hepatitis vaccination prior to travelling.

Book your Hepatitis B vaccination appointment now

Measles on the rise:

The World Health Organisation (WHO), has reported that measles cases are on the rise worldwide and in Europe alone, outbreaks have surged to a 20-year high.

The WHO states that reported measles cases (provided by each country) currently show that about 229,000 cases have already been reported, compared with 170,000 for 2017. Worryingly the 2018 number is likely to rise as the reporting deadline ends April ’19.

With a 50% increase in measles cases last year, it is important to understand the benefits of vaccinating against measles:

Dr Richard Dawood, our Medical Director explains;

“I recently heard about a patient suffering a bad attack of shingles. She didn’t believe in doctors, medicines or vaccines, I was told, and was languishing at home, with a dreadful, crusted rash across her body, and burning with pain. She had stuck to her beliefs and refused to take antiviral medication that could have aborted the attack or reduced the probability of ending up with long term nerve damage and lingering pain. Shingles can strike more than once, but since she doesn’t believe in vaccines (there is a good one that is 95% effective) she will have to take her chances of a recurrence in future. I disagree with her opinions, but her latest actions will harm nobody but herself.

But measles is different: when it comes to vaccination, personal choices and opinions have a direct impact on the health and wellbeing of others – individually as well as for entire communities. Measles vaccination is a major public health issue. Memories of the past outbreaks, epidemics, tragic disability and loss of life that drove research and ground-breaking vaccine development now belong to a previous generation. In these days of “fake news”, “influencers” and social networks, it has become too easy to undermine confidence in matters of public health. In the case of measles, concerns about vaccine safety are down to the “fake research” of Andrew Wakefield, who was struck off the medical register for concocting a spurious link with autism in the 1990s. But the damage was long-lasting.

The complications of measles are most severe in babies who are not yet old enough to be vaccinated, and children with reduced immunity. When the rate of vaccination in the general population falls below 95%, outbreaks occur and can easily spread, with the highest impact on those most vulnerable populations, undermining years of hard work around the world to bring measles under control.

That is what is happening now”.